HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab.

Abstract
Although immunosuppressed patients may be more prone to SARS-CoV-2 infection with atypical presentation, long-term immunosuppression therapy may provide some sort of protection for severe clinical complications of COVID-19. The interaction between immunosuppression and new antiviral drugs in the treatment of transplanted patients contracting COVID-19 has not yet been fully investigated. Moreover, data regarding the optimal management of these patients are still very limited. We report a case of the successful recovery from severe COVID-19 of a kidney-transplanted patient treated with hydroxychloroquine, lopinavir/ritonavir, steroid, and tocilizumab.
AuthorsAndrea Lauterio, Mila Valsecchi, Sara Santambrogio, Riccardo De Carlis, Marco Merli, Angelo Calini, Leonardo Centonze, Vincenzo Buscemi, Maurizio Bottiroli, Massimo Puoti, Roberto Fumagalli, Luciano De Carlis
JournalTransplant infectious disease : an official journal of the Transplantation Society (Transpl Infect Dis) Vol. 22 Issue 5 Pg. e13334 (Oct 2020) ISSN: 1399-3062 [Electronic] Denmark
PMID32449235 (Publication Type: Case Reports, Journal Article)
Copyright© 2020 Wiley Periodicals LLC.
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Heparin, Low-Molecular-Weight
  • Immunosuppressive Agents
  • Lopinavir
  • Hydroxychloroquine
  • Prednisolone
  • tocilizumab
  • Ritonavir
Topics
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antiviral Agents (therapeutic use)
  • COVID-19 (diagnosis, immunology, therapy, virology)
  • Drug Therapy, Combination (methods)
  • Female
  • Graft Rejection (immunology, prevention & control)
  • Heparin, Low-Molecular-Weight (therapeutic use)
  • Humans
  • Hydroxychloroquine (therapeutic use)
  • Immunosuppression Therapy (adverse effects)
  • Immunosuppressive Agents (adverse effects)
  • Kidney Transplantation (adverse effects)
  • Lopinavir (therapeutic use)
  • Lung (diagnostic imaging)
  • Middle Aged
  • Prednisolone (therapeutic use)
  • Respiration, Artificial
  • Ritonavir (therapeutic use)
  • SARS-CoV-2 (immunology, isolation & purification)
  • Severity of Illness Index
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: